These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8735820)

  • 1. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid.
    Lechi C; Gaino S; Tommasoli R; Zuliani V; Bonapace S; Fontana L; Degan M; Lechi A; Minuz P
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):206-9. PubMed ID: 8735820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
    Lechi C; Andrioli G; Gaino S; Tommasoli R; Zuliani V; Ortolani R; Degan M; Benoni G; Bellavite P; Lechi A; Minuz P
    Thromb Haemost; 1996 Nov; 76(5):791-8. PubMed ID: 8950792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid.
    Minuz P; Lechi C; Tommasoli R; Gaino S; Degan M; Zuliani V; Bonapace S; Benoni G; Adami A; Cuzzolin L
    Thromb Res; 1995 Dec; 80(5):367-76. PubMed ID: 8588198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
    Corazzi T; Leone M; Maucci R; Corazzi L; Gresele P
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1331-7. PubMed ID: 16144976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
    Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
    J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans.
    Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P
    J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
    de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
    Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of aspirin and two nitric oxide donors on the infarcted heart in situ.
    Yamamoto T; Kakar NR; Vina ER; Johnson PE; Bing RJ
    Life Sci; 2000 Jul; 67(7):839-46. PubMed ID: 10968413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
    Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
    Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood.
    González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP
    Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alditols and monosaccharides from sorghum vinegar can attenuate platelet aggregation by inhibiting cyclooxygenase-1 and thromboxane-A2 synthase.
    Li J; Yu G; Fan J
    J Ethnopharmacol; 2014 Aug; 155(1):285-92. PubMed ID: 24877847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils.
    Sánchez de Miguel L; Casado S; Farré J; García-Durán M; Rico LA; Montón M; Romero J; Bellver T; Sierra MP; Guerra JI; Mata P; Esteban A; López-Farré A
    Eur J Pharmacol; 1998 Feb; 343(1):57-65. PubMed ID: 9551715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.